{"DataElement":{"publicId":"6609370","version":"1","preferredName":"Proteasome Inhibitor Assessment Status","preferredDefinition":"The condition or state related to proteasome inhibitor.","longName":"PROTM_INHBT_ASSM_ST","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6609350","version":"1","preferredName":"Proteasome Inhibitor Assessment","preferredDefinition":"Any substance that inhibits the proteasome complex, an enzyme complex responsible for degradation of ubiquitinated proteins. Inhibition of proteasome activity and ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins, which may result in the disruption of cellular processes, cell cycle arrest, the induction of apoptosis, and the inhibition of tumor growth and angiogenesis._The final result of a determination of the value, significance, or extent of.","longName":"5084012v1.0:2233077v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"5084012","version":"1","preferredName":"Proteasome Inhibitor","preferredDefinition":"Any substance that inhibits the proteasome complex, an enzyme complex responsible for degradation of ubiquitinated proteins. Inhibition of proteasome activity and ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins, which may result in the disruption of cellular processes, cell cycle arrest, the induction of apoptosis, and the inhibition of tumor growth and angiogenesis.","longName":"C2160","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proteasome Inhibitor","conceptCode":"C2160","definition":"Any substance that inhibits the proteasome complex, an enzyme complex responsible for degradation of ubiquitinated proteins. Inhibition of proteasome activity and ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins, which may result in the disruption of cellular processes, cell cycle arrest, the induction of apoptosis, and the inhibition of tumor growth and angiogenesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"26A038D6-5BD6-6FB4-E050-BB89AD430AF2","latestVersionIndicator":"Yes","beginDate":"2015-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-11","modifiedBy":"ONEDATA","dateModified":"2015-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233077","version":"1","preferredName":"Assessment","preferredDefinition":"The final result of a determination of the value, significance, or extent of.","longName":"C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F90B5E56-BAFE-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-08","modifiedBy":"ONEDATA","dateModified":"2005-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F7030EF-CBD8-1043-E053-F662850AAF3C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-14","modifiedBy":"SOKKERL","dateModified":"2019-02-26","changeDescription":"1/14/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6609362","version":"1","preferredName":"Inhibitor Status","preferredDefinition":"A class of substances that binds to and inhibits the function or activity of a target._A condition or state at a particular time.","longName":"6609362v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Refractory","valueDescription":"PI Refractory","ValueMeaning":{"publicId":"6609371","version":"1","preferredName":"PI Refractory","longName":"6609371","preferredDefinition":"PI Refractory","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6FC222-1BC9-5AF1-E053-F662850A1151","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F6FC222-1BE2-5AF1-E053-F662850A1151","beginDate":"2019-01-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","deletedIndicator":"No"},{"value":"Sensitive","valueDescription":"PI Sensitive","ValueMeaning":{"publicId":"6609372","version":"1","preferredName":"PI Sensitive","longName":"6609372","preferredDefinition":"PI Sensitive","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6FC222-1BEC-5AF1-E053-F662850A1151","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F6FC222-1C05-5AF1-E053-F662850A1151","beginDate":"2019-01-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","deletedIndicator":"No"},{"value":"PI-refractory","valueDescription":"Proteasome inhibitor-refractory","ValueMeaning":{"publicId":"6681222","version":"1","preferredName":"Proteasome inhibitor-refractory","longName":"6681222","preferredDefinition":"Proteasome inhibitor-refractory","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EC1763-FE1F-5293-E053-F662850A2B3F","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84EC1763-FE38-5293-E053-F662850A2B3F","beginDate":"2019-03-25","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","deletedIndicator":"No"},{"value":"PI-sensitive","valueDescription":"Proteasome inhibitor-sensitive","ValueMeaning":{"publicId":"6681223","version":"1","preferredName":"Proteasome inhibitor-sensitive","longName":"6681223","preferredDefinition":"Proteasome inhibitor-sensitive","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EC1763-FE42-5293-E053-F662850A2B3F","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84EC1763-FE5B-5293-E053-F662850A2B3F","beginDate":"2019-03-25","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6609361","version":"1","preferredName":"Inhibitor Status","preferredDefinition":"A class of substances that binds to and inhibits the function or activity of a target.:A condition or state at a particular time.","longName":"C154898:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inhibitor","conceptCode":"C154898","definition":"A class of substances that binds to and inhibits the function or activity of a target.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F704100-2EC2-0808-E053-F662850A35DA","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F704100-2ED3-0808-E053-F662850A35DA","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-14","modifiedBy":"SOKKERL","dateModified":"2019-03-25","changeDescription":"1/14/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Proteasome Inhibitor (PI) sta","type":"Preferred Question Text","description":"Proteasome Inhibitor (PI) status","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Proteasome inhibitor","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F700863-4CCB-06B3-E053-F662850A468B","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-14","modifiedBy":"SOKKERL","dateModified":"2019-03-25","changeDescription":"1/14/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}